BCL6 and diffuse large B-cell lymphoma: By contrast, DHL characterized chromosomal translocations involving MYC, BCL6 and BCL2 is a rare disease, representing approximately 5% of all DLBCL cases in our study, indicating that, in addition to translocations, protein expression could be regulated by other mechanisms including other types of rearrangements, amplifications, mutation, or by miRNA-depandent mechanisms [30]–[32].